Precision medicine marks a new era of cancer treatment and provides more effective, precise, and safer therapies.
Our cancer genomics testing, medical oncology, and genetic counseling services help determine optimal precision medicine strategies for patients. Elsee Medicine offers Elsee Cancer 200, and Elsee Screen Premium tests to detect germline genetic variants that increase the risk for cancer. These tests are very helpful for early cancer detection and effective prevention.
In addition, our company also partners with Foundation Medicine to offer FoundationOne somatic cancer gene mutations tests for optimizing personalized cancer treatment.
Elsee Cancer 200
A whole exome screening assay sequencing the protein-encoding regions of 24000 genes.
This assay is designed to detect important germline genetic defects and mutations that may increase the risk for cancer.
Elsee Screen Premium
A comprehensive screening assay sequencing your whole genome.
This test is designed for detecting more than 50 million germline genetic mutations that may increase the risk for cancer and other genetic disorders.
Focused genomics analysis assays for solid tumors and hematological malignancies.
The tests provide doctors with clinically actionable insights for guiding and optimizing therapeutic plans.
Ashion - WES - 24000
Comprehensive genomics analysis assays for solid tumors and hematological malignancies. These tests analyzes more than 24,000 genes in tumor and germline genomes to guide therapeutic decisions.
In addition to cancer genomics assays, Elsee Medicine also provides advanced medical genetic tests and counseling for a variety of genetic disorders in the following categories:
We currently offer medical genetics analysis and counseling for genetics disorders in the following categories:
Pediatrics and Development disorders
Reproductive Health and Fertility